“✉구글 찌라시 프로그램 [ 텔레 : ADSFIX01 ] 구글백링크프로그램 구글찌라시광고✉”的搜索结果，显示 261-270 项，共有 12250 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... program that can be implemented and studied in the future. We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... program that is more easily accessible by patients. Frailty is thought to be mediated by senescent cells and their dynamic secretome, referred to as the ...

3. 皮肤科- 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... program that can be implemented and studied in the future. We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... program that can be implemented and studied in the future. We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

7. 小儿神经外科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in ...

8. 小儿外科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine whether a posterior fossa decompression or a posterior fossa decompression with duraplasty results in ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Jacksonville, Fla. The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) ...